Navigation Links
Thoratec Schedules Fourth Quarter Conference Call, Webcast
Date:1/21/2011

PLEASANTON, Calif., Jan. 21, 2011 /PRNewswire/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for fiscal year 2010 on Thursday, January 27.

The company will hold a conference call to discuss its financial results and operating activities open to all interested parties at 1:30 p.m., Pacific Standard Time (4:30 p.m., Eastern Standard Time), Thursday, January 27, hosted by Gary F. Burbach, president and chief executive officer, and David V. Smith, executive vice president and chief financial officer.

The teleconference can be accessed by calling (719) 457-2728, passcode 5849363. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will be available on the Internet at http://phx.corporate-ir.net/phoenix.zhtml?p=irol-eventDetails&c=95989&eventID=3661103 or at http://www.thoratec.com.

A replay of the conference call will be available through Thursday, February 3, via http://www.thoratec.com or by telephone at (719) 457-0820, passcode 5849363.

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate® LVAS (Left Ventricular Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than 15,000 devices implanted in patients suffering from heart failure. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web site at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate and HeartMate II are registered trademarks of Thoratec Corporation and IVAD is a trademark of Thoratec Corporation.


'/>"/>
SOURCE Thoratec Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thoratec Presentation at J.P. Morgan Conference to Be Webcast
2. Thoratec Announces Webcast of Investor Presentation at American Heart Association Meeting
3. Thoratec Reports 40 Percent Increase in Third Quarter Revenues From Continuing Operations
4. Thoratec Schedules Third Quarter Conference Call, Webcast
5. Thoratec to Present at Upcoming Investor Conferences
6. Thoratec Announces Termination of Proposed Sale of ITC
7. Thoratec Schedules Second Quarter Conference Call, Webcast
8. Thoratec Announces Early Termination of HSR Waiting Period for the Sale of ITC to Danaher Corporation
9. Thoratec Presentation at Raymond James Conference to Be Webcast
10. Thoratec Reports a 19 Percent Increase in Annual Revenues as Cardiovascular Division Revenues Increase 30 Percent in 2009
11. Thoratec Announces Acquisition of Innovative Catheter-Based Heart Pump Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2016)... The global  parenteral nutrition ... by 2024, according to a new report by ... the growing malnutrition coupled with the prevalence of ... diseases are expected to boost the market over ... http://photos.prnewswire.com/prnh/20150105/723757 ) , The presence ...
(Date:5/30/2016)... - DCGI grants limited approval to market Stempeucel® product for treating ... becomes 5th off-the-shelf Stem cell product to be approved by a ... (also known as Thromboangiitis Obliterans) is a major unmet medical need ... Prevalence of Buerger,s Disease is estimated to be 1,000,000 in ... European Community & USA Stempeutics ...
(Date:5/30/2016)... 2016 Eye expert s ... to seek an eye examination before ...   Moorfields Eye Hospital Dubai, the first overseas ... , has identified premature babies as a special concern in ... particular vulnerability to retinopathy of prematurity (ROP). ROP is a potentially ...
Breaking Medicine Technology:
(Date:5/31/2016)... York, New York (PRWEB) , ... May 31, 2016 , ... ... effects research to provide the best accessories to avoid excessive Smartphone radiation implicated in ... of the study released on the bioRxiv preprint server on May 26th ...
(Date:5/31/2016)... ... June 01, 2016 , ... Psoriasis: Targets and Therapy ... , As corresponding author Professor Luigi Naldi says “The review in Psoriasis: Targets ... Smoking influences the onset and the severity of psoriasis, and negatively influences the ...
(Date:5/31/2016)... ... May 31, 2016 , ... Fire ... CDC, has joined the Fire Door Solutions’ team. Keith will serve Fire ... and frame in-field re-labeling. He will be instrumental in developing educational curriculum ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... that considers individuals’ genetic characteristics and the physical and behavioral worlds in ... in sync. In personalized medicine, diagnosing an individual’s disease depends on accurately ...
(Date:5/31/2016)... CA (PRWEB) , ... May 31, 2016 , ... Throughout the day, adults often find ... sustained motivation and awareness, but what they could be reaching for instead is a cup ... plants that are grown in Japan. This sacred tea is harvested from early June to ...
Breaking Medicine News(10 mins):